ICU sedation, delirium & recovery

Timing matters: sex differences in treatment limitation decisions in intensive care

Crit CarePublished Nationwide cohort study

Authors' conclusion

In Switzerland, sex differences in treatment limitations occur mainly at ICU admission and vary across diagnoses.

Study context

Population
Adult (≥ 18 years) ICU admissions, Swiss Minimal Dataset for Intensive Care Units, 2016–2024
Participants
654,660 ICU stays
Exposure
Women vs men
Outcome
Treatment limitations documented at ICU admission and those occurring later among patients admitted without limitations
Methodological detailsnationwide registry, adjusted logistic regression
  • Nationwide registry
  • Adjusted logistic regression

Main finding

As reported in the abstract

Treatment limitations at ICU admission · ICU admission
Female sex independently associated with limitations at admission
aOR 1.26 (1.24-1.28) (95% CI)

Observational data: associations, not effects.

Further findings

Treatment limitations during ICU stay (patients admitted without limitations) · adjusted logistic regression

Treatment limitations during ICU stay (patients admitted without limitations) — Female sex only weakly associated with later limitations
aOR 1.10 (1.08-1.13) (95% CI)

Limitations at admission by diagnosis (subgroup)

Differences at admission varied by diagnosis, most pronounced in trauma and cardiovascular conditions

Type of limitation decision

Women more often ceiling-of-care decisions and documented patient wishes; men more often withdrawal of life-sustaining therapies and physician-driven decisions

Mortality by limitation category

Highest with limitations at ICU admission, lowest without limitations; minimal sex differences within categories

Original publication

Timing matters: sex differences in treatment limitation decisions in intensive care. Crit Care. Published 19 June 2026. doi:10.1186/s13054-026-06139-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.